Company performance
Current Price
as of Jan 10, 2025$262.23
P/E Ratio
33.58
Market Cap
$140.96B
Description
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Metrics
Overview
- HQThousand Oaks, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerAMGN
- Price$262.23-0.75%
Trading Information
- Market cap$140.96B
- Float99.76%
- Average Daily Volume (1m)3,661,328
- Average Daily Volume (3m)3,443,157
- EPS$7.88
Company
- Revenue$32.32B
- Rev growth (1yr)23.11%
- Net income$2.83B
- Gross margin60.87%
- EBITDA margin40.17%
- EBITDA$3.40B
- EV$226.03B
- EV/Revenue6.99
- P/E33.58
- P/S4.40
- P/B18.73
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset